Kathryn Lee-Young
Adult Health · Westminster, MDNPI 1629495155
Payments from drug & device makers
Across 158 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$730
- Takeda Pharmaceuticals U.S.A., Inc.$524
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$427
- Madrigal Pharmaceuticals$337
- Ipsen Biopharmaceuticals, Inc$306
- Gilead$201
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,616100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $730 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $524 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $427 |
| Madrigal Pharmaceuticals | 13 | $337 |
| Ipsen Biopharmaceuticals, Inc | 12 | $306 |
| Gilead | 8 | $201 |
| Daiichi Sankyo Inc. | 6 | $145 |
| Orphalan Inc | 5 | $124 |
| Intercept Pharmaceuticals, Inc. | 5 | $119 |
| Ironwood Pharmaceuticals, Inc | 6 | $117 |
| Sanofi | 3 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| QOL Medical, LLC | 3 | $77 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 1 | $38 |
| Amgen | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| Celltrion USA Inc. | 2 | $32 |
| Digestive Care, Inc. | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Organon | 2 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Novo Nordisk | 1 | $21 |
| Merck | 1 | $19 |
| Braintree Laboratories, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REZDIFFRA$113
How this compares
$3,616 in reported general payments places this provider in the 85th percentile of 542 adult health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 91 | $312,732 |
| OcalivaObeticholic Acid | 21 | $201,383 |
| VemlidyTenofovir Alafenamide | 42 | $60,432 |
| Envarsus XrTacrolimus | 22 | $26,953 |
| Ursodiol | 117 | $22,476 |
| Entecavir | 51 | $17,745 |
| Tacrolimus | 110 | $16,556 |
| EliquisApixaban | 12 | $14,215 |
| Lamivudine HbvLamivudine | 12 | $5,429 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 208 | $4,248 |
| Sirolimus | 13 | $3,317 |
| Cyclosporine ModifiedCyclosporine, Modified | 21 | $3,039 |
| Azathioprine | 54 | $2,802 |
| Mycophenolate Mofetil | 39 | $2,009 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 23 | $1,250 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $427 | $312,73291 claims |
| Intercept Pharmaceuticals, Inc.Ocaliva | $119 | $201,38321 claims |
| GileadVemlidy | $201 | $60,43242 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 542 adult health providers in Maryland.
Other adult health in Westminster
- April BentleyWestminster$10K
- Lucia NovakCamp Springs$473K
- Caroline RuhlAnnapolis$315K
- Joyce MiskovicHighland$264K
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Angie PriceBaltimore$96K
- Morgan JoliatSykesville$92K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.